[Skip to Navigation]
Sign In
November 2016

Incorrect Affiliations and Updated Supplement

JAMA Oncol. 2016;2(11):1511. doi:10.1001/jamaoncol.2016.4680

In the Original Investigation titled “Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer” published online June 4, 2016,1 an error occurred in the author affiliations, as well as in the online supplemental material. The affiliations “Epic Sciences, La Jolla, California” and “Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York” were inverted, and table headers were added to eTable 1 in the Supplement. This article was corrected online.

Scher  HI, Lu  D, Schreiber  NA,  et al.  Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer  [published online June 4, 2016].  JAMA Oncol. doi:10.1001/jamaoncol.2016.1828Google Scholar